Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sage Therapeutic Com
(NQ:
SAGE
)
13.94
+0.83 (+6.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sage Therapeutic Com
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Looking For Bargains Among The Rubble
June 20, 2021
Last week was tough. Nearly everything publicly traded took a hit. In this article I drill down into the market to take account of where the damage was the worst, and maybe identify a few bargains...
Via
Talk Markets
Here's Why Sage Therapeutics Tanked This Week
June 19, 2021
The neuroscience-focused biotech company didn't give investors the result they wanted.
Via
The Motley Fool
Biogen Discontinues Tau Antibody Program For Alzheimer's After Mid-Stage Study Flops
June 17, 2021
Biogen Inc (NASDAQ: BIIB) has four other Alzheimer’s candidates in its clinical pipeline behind recently-approved Aduhelm, of which one has just been canned. The...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2021
June 16, 2021
Upgrades According to Piper Sandler, the prior rating for First Bancorp (NASDAQ:
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
June 16, 2021
Morgan Stanley raised NIKE, Inc. (NYSE:NKE) price ta...
Via
Benzinga
44 Biggest Movers From Yesterday
June 16, 2021
Gainers Alzamend Neuro, Inc. (NASDAQ: ALZN) shares jumped 170% to close at $13.50 on Tuesday after the company priced its IPO at $5 per share. Alfi, Inc. (NASDAQ: ALF) shares...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Mid-Afternoon Market Update: Nasdaq Down 100 Points; Clearside Biomedical Shares Spike Higher
June 15, 2021
Toward the end of trading Tuesday, the Dow traded down 0.19% to 34,326.95 while the NASDAQ fell 0.70% to 14,074. The S&P also fell, dropping 0.12% to 4,249.99. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 15, 2021
Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 26.21% to $3.81 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...
Via
Benzinga
Here's Why Sage Therapeutics Stock Is Sliding Today
June 15, 2021
Long-awaited clinical trial results weren't as successful as hoped.
Via
The Motley Fool
Mid-Day Market Update: Crude Oil Rises 1%; Sage Therapeutics Shares Slide
June 15, 2021
Midway through trading Tuesday, the Dow traded down 0.45% to 34,238.18 while the NASDAQ fell 0.53% to 14,099.27. The S&P also fell, dropping 0.25% to 4,244.45. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
34 Stocks Moving In Tuesday's Mid-Day Session
June 15, 2021
Gainers HMG/Courtland Properties, Inc. (NYSE: HMG) shares surged 133% to $27.80. Alfi, Inc. (NASDAQ: ALF) shares jumped 82.1% to $6.21 after the company inked an agreement with...
Via
Benzinga
Biogen Analyst Raises Price Target On Higher Chance Of Success For Depression Drug
June 15, 2021
Biogen Inc. (NASDAQ: BIIB) stock is seeing muted sentiment Tuesday as it emerges from the euphoria over Aduhelm approval, with the most recent trigger being lukewarm data for a...
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; US Retail Sales Drop 1.3% In May
June 15, 2021
Following the market opening Tuesday, the Dow traded down 0.34% to 34,275.92 while the NASDAQ fell 0.09% to 14,161.73. The S&P also fell, dropping 0.10% to 4,250.89. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Sage Stock Tumbles As Analysts Question Its 'Positive' Test In Depression
June 15, 2021
The results showed an improvement over placebo. But that improvement waned over time.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 15, 2021
Gainers Clearside Biomedical (NASDAQ:CLSD) stock increased by 50.99% to $4.56 during Tuesday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
Why Sage Therapeutics (SAGE) Stock Is Falling Despite Meeting Primary Endpoint In Major Depressive Disorder Trial With Zuranolone
June 15, 2021
Looking to make a comeback after a big Phase 3 flop, Sage Therapeutics Inc (NASDAQ: SAGE) revealed data from another Phase 3 evaluating zuranolone in patients with...
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
June 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Sage Therapeutics to Host Conference Call
June 15, 2021
From
Sage Therapeutics
Via
Business Wire
Sage Therapeutics - Biogen's Zuranolone Tops Placebo In Reducing Depressive Symptoms
June 15, 2021
Sage Therapeutics Inc (NASDAQ: SAGE) and Biogen Inc (NASDAQ: BIIB) have announced data from WATERFALL Phase 3 study evaluating zuranolone (SAGE-217/...
Via
Benzinga
Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder
June 15, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
With Aduhelm Approval Behind Biogen, 5 Catalysts For Investors To Watch
June 10, 2021
Biogen Inc. (NASDAQ: BIIB) made history of sorts with the FDA approval for its Alzheimer's treatment Aduhelm. Notwithstanding the still-raging debate over the decision, an...
Via
Benzinga
Exposures
Product Safety
3 Biotech Stocks With Huge Catalysts in June
June 02, 2021
Binary events expected this month could have enormous implications for these drugmakers and their shareholders.
Via
The Motley Fool
Exposures
Product Safety
The Fight Against Alzheimer's Reaches A Moment Of Truth For Biogen, Other Biotech Stocks
May 21, 2021
The FDA will soon review aducanumab, possibly the first new Alzheimer's treatment in years. Stakes are high for Biogen stock — and other biotech stocks too.
Via
Investor's Business Daily
Exposures
Product Safety
Sage Therapeutics Joins MTV Entertainment Group and More Than 1,300 Leading Organizations to Participate in Inaugural Mental Health Action Day
May 20, 2021
From
Sage Therapeutics
Via
Business Wire
Betting Big On What Could Be The Next Great Biotech Boom
May 18, 2021
Via
FinancialNewsMedia
Sage Therapeutics to Host Sage Science Spotlight: SAGE-718 In Depth
May 13, 2021
From
Sage Therapeutics
Via
Business Wire
Sage Therapeutics Inc (SAGE) Q1 2021 Earnings Call Transcript
May 05, 2021
SAGE earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
May 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Sage Therapeutics Announces First Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
May 04, 2021
From
Sage Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For May 4, 2021
May 04, 2021
Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.